Back

Predictors on admission associated with successful weaning and in-hospital mortality in patients with refractory shock undergoing veno-arterial extracorporeal menbrane oxygenation

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment 6 Ventricular Assist Devices HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Ji Yeon Hong

Hallym University Sacred Heart Hospital, Anyang-Si- Gyeonggi-Do (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Identifying predictors of non-response to cardiac resynchronization therapy in heart failure patients
Doctor L. Pinheiro (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Predictors of cardiac resynchronized therapy response and maximum allowable medical treatment period in dilated cardiomyopathy with left bundle branch block
Doctor M. Bak (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronisation therapy's response in patients with atrial fibrillation
Doctor A. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Longitudinal assessment of ventricular arrhythmia burden before and after left ventricular assist device implantation: implications for risk stratification and postoperative management
Professor M. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of heart failure hospitalization after left ventricular assist device insertion
Doctor M. Bak (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment 6

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella
thumbnail
Congress Presentation
Predictors of mortality in patients with cardiogenic shock and veno-arterial extracorporeal membrane oxygenation
thumbnail
Congress Presentation
Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources